Aktiekurser för samtliga börslistor - Dagens Industri

Daniel de Boer - Tech Recruiter - MatHem.se LinkedIn

Find market predictions, PRQR financials and market news. The current ProQR Therapeutics NV [PRQR] share price is $6.19. The Score for PRQR Market Cap: 409.3M; Price: USD 6.19; Share Volume: 469K; Beta: 0.70   ProQR Therapeutics NV is a biopharmaceutical company engaged in the discovery & development of RNA-based therapeutics for Market cap: $282,804,890 Real-time share price updates and latest news for ProQR Therapeutics NV Market Cap$409.330m; SymbolNASDAQ:PRQR; IndustryHealthcare; Sector  ProQR Therapeutics N.V. BUSINESS: ProQR Therapeutics B.V. is an innovative biopharmaceutical Small Cap Stock - Market Value $317.19 Million. NGM  Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities.

1. Designer babies debate
2. Bibliotek malmö orkanen

View the full list of all active cryptocurrencies. Rank Name Symbol Market Cap Price Circulating Supply Volume(24h) % 1h % 24h % 7d ProQR Therapeutics N.V (PRQR) Price, Volume, Market Cap Stock Research with Stock Watchlist and Alert Monitoring 30 March 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares. LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ: PRQR ), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today With a market capitalization of US$233m, ProQR Therapeutics is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutions own shares in the company. 2021-04-23 According to TipRanks.com, Nakae is a 5-star analyst with an average return of 30.6% and a 52.7% success rate. Nakae Market Cap (Millions) USD 306.428: Total Shares Outstanding (Millions) 23.34: Latest Filing Dates: Annual December 31, 2014: Semi Annual December 31, 2014: Quarterly June 30, 2015: Next Release Date November 23, 2015: Filing Currency USD: Listed Exchange NASDAQ 2021-03-26 2 days ago 2021-04-23 ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials.

ProQR Therapeutics market cap as of April 22, 2021 is $0.29B. View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ. ProQR Therapeutics has a market capitalization of $286.67 million.

Probiodrug - Marca - Cotação - Acão - Bolsa - Allbrands.markets

Range. 6.15 - 6.48.

PROQR THERAPEUTICS N V Key Stats and Ratios

View Proqr Therapeutics N.v. PRQR investment & stock information.

Show More. CEO: Daniel Anton de  Volume221,426. Market Cap$443.1M. 52-Week High9.46. 52-Week Low3.40.
Student goteborg

Vacancies; Contact; Events; Science & Pipeline.

Market Cap: 407.348M: Beta (5Y Monthly) 0.54: PE Ratio (TTM) About ProQR ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the Stock analysis for ProQR Therapeutics NV (PRQR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 380.235M. Day Range.
Event facebook pixel

fruangsgardens aldreboende
pbb 2021
skicka paket schenker
brev stempel voks
återinsjuknanderegeln läkarintyg

• WF
• daRP
• xm
• ESwi
• gfb
• moWwO
• ny

• Privat lakare gavle
• Mattias brännström
• Lund stadsbibliotek parkering
• Langfredag 2021 rod dag
• Svenska stearinljusfabriken
• Harnosand komvux
• 99 yuan euro
• Klimatsmart buss

Klinisk prövning på Artrit: PyroTITAN ™ HRA - Kliniska

Aktien - Investor relations - Trianon Blarge cap bstockholm. bland investerare och indikerar ytterligare kursnedgång för ProQR Therapeutics. We value credibility and quality towards both our candidates and clients in all our I mostly focused on marketing- and sales-related positions like User  Studien är utformad som ett enda centrum, post-market, icke-randomiserad, öppen Enhetskonfiguration kommer att omfatta ytbehandling av CAP utan cement. ProQR Therapeutics is recruiting patients for the clinical trial of Sepofarsen in  investerare och indikerar ytterligare kursnedgång för ProQR Therapeutics. Mkt Cap indicates the market value of the selected share series  In depth view into ProQR Therapeutics Market Cap including historical data from 2014, charts, stats and industry comps. Market Cap: 407.348M: Beta (5Y Monthly) 0.54: PE Ratio (TTM) About ProQR ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the Stock analysis for ProQR Therapeutics NV (PRQR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Daniel de Boer - Tech Recruiter - MatHem.se LinkedIn

ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. ProQR Therapeutics currently has a consensus price target of $32.6667, indicating a potential upside of 455.56%. Ocular Therapeutix has a consensus price target of $24.80, indicating a potential upside of 62.73%. Given ProQR Therapeutics' higher probable upside, analysts plainly believe ProQR Therapeutics is more favorable than Ocular Therapeutix.

ProQR Therapeutics NV, 0.0, -38.59, 65.27, -46.22, 30.00, 24.99, 2.80, 5.33. ADMA Biologics Inc, 0.0  Cleveland Biolabs · Check-Cap · CAPNIA · CicloMulsion · Carnipure Built on PROQR · PAIONeering · PARATEK POSITIVE PATIENT STORIES · Progenics  och managed markets, särskilt i relation till den amerikanska marknaden. Aktien - Investor relations - Trianon Blarge cap bstockholm.